ReviewSignal transduction and targeted therapy2022
SARS-CoV-2 Omicron variant: recent progress and future perspectives.
Yao Fan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
339 papers cite itlatest 60 shown
this paperpooled ittrialcites it